Structuring Collaborative Agreements in Life Sciences
Drafting Terms to Expand Product Lines, Reduce Costs and Risks, and Leverage and Protect Assets
Recording of a 90-minute premium CLE webinar with Q&A
This CLE course will provide guidance to counsel for companies in the life sciences industry for structuring collaborative agreements. The panel will discuss key considerations including allocation of risk, establishment of milestones and obligations, protection of IP rights, and termination of agreements.
Outline
- Key considerations
- Contract terms
- Risk allocation
- Roles of parties
- Establishing milestones
- Party obligations
- Development and marketing
- IP rights
- Termination
- Best practices
Benefits
The panel will review these and other key issues:
- What considerations and potential pitfalls should counsel keep in mind when crafting collaborative agreements?
- What are the key contract terms that should be included in life sciences collaborative agreements?
- What approaches are most effective for assigning ownership and development rights?
Faculty
Judith A. Hasko
Partner, Vice Chair Healthcare & Life Sciences Practice
Latham & Watkins
Ms. Hasko advises life sciences companies and investors on a wide range of technology-based commercial matters. She... | Read More
Ms. Hasko advises life sciences companies and investors on a wide range of technology-based commercial matters. She represents companies developing biotechnology, pharmaceutical, medical device and diagnostic products, and their investors on matters, including licensing and corporate partnering, joint ventures, co-promotion arrangements, manufacturing and distribution agreements, asset purchases, and royalty stream purchases and sales. Ms. Hasko brings complementary business and scientific perspectives to her legal representations. She is a Certified Licensing Professional (CLP), and a member of the Patent Bar. Ms. Hasko has co-authored several scientific publications and frequently lectures on life sciences commercial topics in both industry and academic settings, including at Berkeley Law and Stanford University.
Close
Amy L. Toro
Partner
Covington & Burling
Ms. Toro advises both pharmaceutical and biotechnology companies regarding biologics, pharmaceuticals and devices,... | Read More
Ms. Toro advises both pharmaceutical and biotechnology companies regarding biologics, pharmaceuticals and devices, including in the digital health space. She works on all types of life sciences transactions, including major collaborations, licensing arrangements, clinical trial agreements, supply and distribution agreements, product development funding deals, and joint ventures and a variety of commercial agreements. Ms. Toro also works with her mergers and acquisition colleagues on product divestitures and asset transfers.
Close